Atlas Trials

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Clinical trial NCT06282796 · RECRUITING

Trial details

NCT number
NCT06282796
Sponsor
First Hospital of China Medical University
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2024-01-01
Primary completion
2026-12-31
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.